NPPB and cardiac hypertrophy: Acetate also downregulates Egr1, a master transcriptional regulator of cardiac and renal inflammation, and signals via GPR43/109a to reduce RAAS activation and cardiac Nppb expression, a marker of cardiac hypertrophy and heart failure [30,38].